It has been shown that activating NF-κB and toll-like receptors (TLRs) increases the production of inflammatory cytokines in the kidney tissue, contributing to the development of AKI following rhabdomyolysis (34). The gene discussed is NFKB1; the disease is rhabdomyolysis.